Investigative Site — Boston, Massachusetts

Investigative Site is a clinical research site located in Boston, Massachusetts, United States 02115.

Crixeo Health Trust Score: 77/100 (FAIR). This profile has not yet been claimed by the site owner.

Investigative Site has participated in 13 clinical trials with 1 currently active.

Therapeutic areas: Multiple Myeloma, Tumor Hyperinsulinism (Tumor HI), AIS.

Sponsors: AEterna Zentaris, Rezolute, CSPC-NBP Pharmaceutical Co., Ltd..

Sponsor Feasibility Report

Trust Score: 77/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Investigative Site?

Investigative Site has a Crixeo Trust Score of 77/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Investigative Site conducted?

Investigative Site has 13 clinical trials on record, with 1 currently active. Their work covers Multiple Myeloma, Tumor Hyperinsulinism (Tumor HI), AIS.

Is Investigative Site accredited by Crixeo Health?

Yes — Investigative Site holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Investigative Site?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.